참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | 2-Pyridinecarboxaldehyde | HCID 14273 | — |
| 반응물 | 5-Bromo-1-methyl-1H-imidazole | HCID 1515258 | — |
| 반응물 | HCID 178461733 | HCID 178461733 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | (1-Methyl-1H-imidazol-5-yl)(pyridin-2-yl)methanol | HCID 86715604 | — |
반응 단계
A solution of isopropylmagnesium chloride/lithium chloride complex (1.3 M in THF, 19.5 mL, 25.35 mmol) was added dropwise by syringe to a solution of 5-bromo-1-methyl-1H-imidazole (4.12 g, 25.58 mmol) in dry THF (130 mL) at 0° C. After 15 minutes, the Grignard solution was added via cannulation to a solution of picolinaldehyde (2.0 ml, 20.93 mmol) in dry THF (55 mL) at 0° C. The reaction mixture was stirred for 5 minutes at 0° C., then warmed to room temperature for 1 hour. The reaction mixture was then cooled in an ice bath and quenched with saturated aqueous ammonium chloride. The mixture was partitioned between brine and ethyl acetate. The separated aqueous phase was further extracted with ethyl acetate. The organic phase was dried (Na2SO4), filtered, and concentrated. The crude product was purified by flash column chromatography (silica gel, 0-5% MeOH-DCM) to provide the title compound as a white solid.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US09328095B2 |
|---|
| 출처 데이터셋 | uspto-grants-2016_05 |
|---|
| ORD ID | ord-ce3ec1c8d3974353a11504b793e9359d |
|---|
| 출처 메모 | uspto-grants-2016_05 |
|---|